Core Viewpoint - The company TianKang (301263.SZ) has received a drug registration certificate from the National Medical Products Administration for Minoxidil topical solution, a commonly used treatment for hair loss [1] Group 1: Company Developments - TianKang's wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd. (referred to as "Huabo Kaisheng"), is responsible for the registration of Minoxidil [1] - The approval of Minoxidil is expected to enhance the company's product portfolio in the hair loss treatment market [1] Group 2: Industry Insights - Minoxidil is a well-known topical treatment for hair loss, functioning as a vasodilator that relaxes blood vessel walls, facilitating blood flow to the scalp and hair follicles [1] - The drug works by catalyzing the formation of the active metabolite Minoxidil sulfate, which stimulates hair follicle growth and promotes the proliferation of atrophied hair follicles [1]
泰恩康(301263.SZ)：子公司收到米诺地尔搽剂药品注册证书